Skeletal Muscle Density as a Predictor of Prognosis and Physical Reserve in Patients with Cancer of Unknown Primary.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 9, p. 2947, doi. 10.3390/jcm14092947
- By:
- Publication type:
- Article
Works matching AU Shin, Kabsoo
Results: 22
1
2
Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 16, p. 5394, doi. 10.3390/jcm12165394
- By:
- Publication type:
- Article
3
Growth Pattern of Hepatic Metastasis as a Prognostic Index Reflecting Liver Metastasis-Associated Survival in Breast Cancer Liver Metastasis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 10, p. 2852, doi. 10.3390/jcm11102852
- By:
- Publication type:
- Article
4
Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor--Positive Metastatic Breast Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1198, doi. 10.4143/crt.2022.1543
- By:
- Publication type:
- Article
5
Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 409, doi. 10.4143/crt.2020.451
- By:
- Publication type:
- Article
6
Clinical Utility of Whole-Genome Analysis as One-for-All Test for Breast Cancer: A Case Series.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
7
Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer.
- Published in:
- Biomedicines, 2025, v. 13, n. 4, p. 976, doi. 10.3390/biomedicines13040976
- By:
- Publication type:
- Article
8
The Role of Pretreatment Serum Interleukin 6 in Predicting Short-Term Mortality in Patients with Advanced Pancreatic Cancer.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 903, doi. 10.3390/biomedicines12040903
- By:
- Publication type:
- Article
9
Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10811-8
- By:
- Publication type:
- Article
10
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-33128-9
- By:
- Publication type:
- Article
11
Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
12
Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer.
- Published in:
- Journal of Gastric Cancer, 2020, v. 20, n. 4, p. 408, doi. 10.5230/jgc.2020.20.e33
- By:
- Publication type:
- Article
13
Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
- Published in:
- 2019
- By:
- Publication type:
- journal article
14
Efficacy of a single 5 mg zoledronic acid infusion in preventing bone loss and fracture in postmenopausal women with breast cancer.
- Published in:
- Journal of Bone & Mineral Metabolism, 2024, v. 42, n. 6, p. 720, doi. 10.1007/s00774-024-01552-0
- By:
- Publication type:
- Article
15
Risk Factors of Developing Leptomeningeal Seeding After Resection of Brain Metastasis in Patients With Breast Cancer: Defining the Indication for Preoperative SRS.
- Published in:
- In Vivo, 2025, v. 39, n. 2, p. 1094, doi. 10.21873/invivo.13914
- By:
- Publication type:
- Article
16
Real-world outcomes of fluorouracil-based second-line therapy in patients with advanced biliary tract cancer refractory to gemcitabine and cisplatin-based treatment.
- Published in:
- Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251335879
- By:
- Publication type:
- Article
17
Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients.
- Published in:
- BMC Endocrine Disorders, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12902-022-01004-8
- By:
- Publication type:
- Article
18
Histologic subtype-based evaluation of recurrence and survival outcomes in patients with adenocarcinoma of the ampulla of Vater.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42386-6
- By:
- Publication type:
- Article
19
Skeletal Muscle Density as a Predictive Marker for Pathologic Complete Response in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemoimmunotherapy.
- Published in:
- Cancers, 2025, v. 17, n. 11, p. 1768, doi. 10.3390/cancers17111768
- By:
- Publication type:
- Article
20
Prognostic Significance of EGFR, HER2, and c-Met Overexpression in Surgically Treated Patients with Adenocarcinoma of the Ampulla of Vater.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2756, doi. 10.3390/cancers16152756
- By:
- Publication type:
- Article
21
Early Increase in Circulating PD-1 + CD8 + T Cells Predicts Favorable Survival in Patients with Advanced Gastric Cancer Receiving Chemotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3955, doi. 10.3390/cancers15153955
- By:
- Publication type:
- Article
22
Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12398-0
- By:
- Publication type:
- Article